The project with our partners from Vilnius University Life Sciences Center started in 2017 and is co-funded by European Union through Intelektas program. The goal is to design a phospholipid bilayer membrane-based sensor for detection of biological toxins in the acute bacterial infectious diseases diagnostics.
Drug encapsulation in macrophage-derived exosomes is a promising strategy in development of targeted delivery systems for treatment of aggressive and therapy-resistant cancer forms. These nanovesicles are naturally produced in human organism and can be applied as targeted delivery devices for treatment of oncological and other serious pathologies.
Using LED technology, this company develops and manufactures complex plant lighting systems, develops their trade. After many years of investment in research and development, the company has earned recognition in Europe – it has been funding the first phase of the EU Framework Program for Research and Innovation Horizon 2020 SME Instrument.
Provides sophisticated analytical, metrology and high-tech manufacturing equipment and provides its services to the largest and most renowned universities and research institutes in the Baltic States. The partners of the company are the most famous international companies such as Carl Zeiss, Bruker AXS, PHI, MBraun and others.
Provides high value added medical products for clients working in orthopedics, surgery, cardiology and radiology in the Baltic States and Ukraine. The partners of the company are all the largest Baltic states hospitals and the most famous international companies such as Abbott, Cook Medical, Maquet, Arthrex, W. Link, and others.
Develops artificial intelligence algorithms to diagnose various diseases and seeks to perfect synergy between technology and medicine. The company is currently implementing project EndoArt funded by the European Regional Development Fund, which aims to develop artificial intelligence algorithms to diagnose, register, and monitor human aortic diseases.